雷尼酸锶治疗骨质疏松症的研究进展

被引：4

作者：

胡细连

谢海宝

机构：

[1] 浙江医院浙江省老年医学研究所

来源：

中国骨质疏松杂志 | 2006年 / 05期

关键词：

骨质疏松症; 腰椎; 骨质疏松; 雷尼酸锶; 骨吸收; 椎骨骨折; BMD; 骨矿化; 破骨细胞; 骨矿含量; 成骨细胞; 安慰剂; 空白剂;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：515 / 517+495 +495

页数：4

共 8 条

[1] S12911-2 reduces bone loss induced by short-term immobilization in rats [J].

Hott, M ;

Deloffre, P ;

Tsouderos, Y ;

Marie, PJ .

BONE, 2003, 33 (01) :115-123

[2]

Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies[J] . J. Y. Reginster,P. J. Meunier.Osteoporosis International . 2003 (3)

[3]

Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis[J] . P. J. Meunier,J. Y. Reginster.Osteoporosis International . 2003 (3)

[4]

Prevention of Early Postmenopausal Bone Loss by Strontium Ranelate: The Randomized, Two-Year, Double-Masked, Dose-Ranging, Placebo-Controlled PREVOS Trial[J] . J. Y. Reginster,R. Deroisy,M. Dougados,I. Jupsin,J. Colette,C. Roux.Osteoporosis International . 2002 (12)

[5] Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice [J].